Author: Nancy Ogbonna

New Evidence Shows Strong Connection Between Autism Spectrum and Skin Disorders

by Nancy Ogbonna - 023

New Evidence Shows Strong Connection Between Autism Spectrum and Skin Disorders Please like and subscribe if you enjoyed this video :-)   Introduction Atopic dermatitis (AD) affects up to 20% of children worldwide, making it the most prevalent chronic inflammatory skin condition

New Treatments for Migraines: What Actually Works in 2025?

by Nancy Ogbonna - 0197

New Treatments for Migraines: What Actually Works in 2025? Introduction Migraine affects approximately 10% of the global population, including 25% of adult women and 9% of children. It ranks as the third leading cause of years lived with disability, according to the 2019 Global Burden of Disease

Remyelination in MS: Scientists Uncover Promising Treatment Pathway

by Nancy Ogbonna - 0114

Remyelination in MS: Scientists Uncover Promising Treatment Pathway Introduction Multiple sclerosis (MS) research has entered a transformative phase with the emergence of two promising therapies aimed at restoring myelin, the protective sheath around nerve fibers that is progressively damaged in MS. Affecting an estimated 2.5 million

Is There a Tuberculosis Vaccine? New Research Brings Fresh Hope in 2025

by Nancy Ogbonna - 093

Is There a Tuberculosis Vaccine? New Research Brings Fresh Hope in 2025 Introduction Tuberculosis claims 1.6 million lives annually, yet the question remains: is there a tuberculosis vaccine that effectively protects adults? Despite the century-old Bacillus Calmette–Guérin (BCG) vaccine’s availability, its limited efficacy in preventing adult pulmonary

Is Clonal Hematopoiesis a New Cardiovascular Risk Factor?

by Nancy Ogbonna - 035

Is Clonal Hematopoiesis a New Cardiovascular Risk Factor? Check back later for a possible video summary. Videos are created for most articles.  Abstract This paper explores growing evidence that links clonal hematopoiesis, particularly clonal hematopoiesis of indeterminate potential (CHIP), to an increased risk of

Stroke Technology in 2025: New Treatments Giving Patients a Second Chance

by Nancy Ogbonna - 075

Stroke Technology in 2025: New Treatments Giving Patients a Second Chance Please like and subscribe if you enjoyed this video :-)   Introduction Stroke remains a major public health concern in the United States, impacting approximately 795,000 individuals each year. However,

Breakthrough: New Alzheimer’s Disease Research Shows Prevention Potential in Clinical Trials

by Nancy Ogbonna - 075

Breakthrough: New Alzheimer’s Disease Research Shows Prevention Potential in Clinical Trials Please like and subscribe if you enjoyed this video :-)   Introduction Recent Alzheimer’s disease research reveals a substantial shift from treatment to prevention strategies, offering new hope for millions worldwide. Clinical

Study Reveals: Neighborhood Stress Directly Linked to Poor Cognitive Development in Children